FIMG
AGIO icon

Financial & Investment Management Group’s Agios Pharmaceuticals AGIO Stock Holding History

Financial & Investment Management Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.83M Sell
39,738
-5,153
-11% -$318K 0.67% 53
2018
Q3 		$3.46M Buy
44,891
+15,633
+53% +$1.26M 1.14% 38
2018
Q2 		$2.46M Buy
+29,258
New +$2.55M 0.78% 44

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Financial & Investment Management Group's AGIO Position: Q4 2018 in Review

Financial & Investment Management Group reduced its Agios Pharmaceuticals (AGIO) stake by 11% in Q4 2018, selling an estimated $318K and leaving 39,738 shares worth $1.83M. The position accounts for 0.67% of the portfolio, ranked #53.

Financial & Investment Management Group first reported a position in AGIO in Q2 2018 and has held it in 3 quarters since. The position peaked at $3.46M in Q3 2018. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

  • Financial & Investment Management Group held 39,738 shares of Agios Pharmaceuticals worth $1.83M as of Q4 2018.
  • Financial & Investment Management Group sold 5,153 Agios Pharmaceuticals shares in Q4 2018, an estimated $318K.
  • Agios Pharmaceuticals made up 0.67% of Financial & Investment Management Group's portfolio in Q4 2018, its #53 holding.
  • Financial & Investment Management Group first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • Financial & Investment Management Group's Agios Pharmaceuticals position peaked at $3.46M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on Financial & Investment Management Group's 13F filing for Q4 2018, filed 30 Jan 2019.